These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38735606)

  • 1. Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations.
    Abutalebi M; Li D; Ahmad W; Mokhtari K; Entezari M; Hashemi M; Fu J; Maghsoudloo M
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132239. PubMed ID: 38735606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin, beta A regulates the transforming growth factor-beta pathway to promote malignant biological behaviour in colorectal cancer.
    He Z; Liang J; Wang B
    Cell Biochem Funct; 2021 Mar; 39(2):258-266. PubMed ID: 32662905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Role of
    Zhang X; Wu T; Qin R; Cai X; Zhou Y; Wang X; Shang Z; Li G; Yang R; Dong C; Li J; Ren Y; Ding R; Li Y
    Front Biosci (Landmark Ed); 2023 Nov; 28(11):301. PubMed ID: 38062804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA INHBA-AS1 promotes colorectal cancer cell proliferation by sponging miR-422a to increase AKT1 axis.
    Lin H; Hong YG; Zhou JD; Gao XH; Yuan PH; Xin C; Huang ZP; Zhang W; Hao LQ; Hou KZ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9940-9948. PubMed ID: 33090398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-β signaling pathway.
    Chen ZL; Qin L; Peng XB; Hu Y; Liu B
    J Cell Physiol; 2019 Aug; 234(10):18065-18074. PubMed ID: 30963572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
    Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
    Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 9. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of INHBA expression in human colorectal cancer.
    Okano M; Yamamoto H; Ohkuma H; Kano Y; Kim H; Nishikawa S; Konno M; Kawamoto K; Haraguchi N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Sekimoto M; Doki Y; Mori M; Ishii H
    Oncol Rep; 2013 Dec; 30(6):2903-8. PubMed ID: 24085226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction.
    Xiao Q; Xiao J; Liu J; Liu J; Shu G; Yin G
    Cell Death Dis; 2022 Mar; 13(3):202. PubMed ID: 35236827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin β-A (INHBA) induces epithelial-mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway.
    Yu Y; Wang W; Lu W; Chen W; Shang A
    Bioengineered; 2021 Dec; 12(1):4681-4696. PubMed ID: 34346300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
    Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
    Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway.
    Li J; He M; Xu W; Huang S
    J Exp Clin Cancer Res; 2019 Apr; 38(1):161. PubMed ID: 30987669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
    Alharbi KS
    Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.
    Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.